Birdwatch Note
2023-05-24 18:54:03 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The Newman-Goldfarb protocol is a well-studied, safe practice for inducing lactation of healthy breast milk in both cis women and trans women who have undergone sufficient hormone replacement therapy. Read more: https://www.nytimes.com/2018/02/15/health/transgender-woman-breast-feed.html Peer-reviewed case studies: https://www.liebertpub.com/doi/10.1089/trgh.2017.0044 https://academic.oup.com/jcem/article/106/5/e2047/6123860?login=false https://www.liebertpub.com/doi/10.1089/trgh.2017.0044
Written by 8BBA91C4957E89E3F3E7375E11B946CC2326AC39FC2BFFD5359824DDE642711C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1661170599354400769
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1661445473943650311
- noteId - 1661445473943650311
- participantId -
- noteAuthorParticipantId - 8BBA91C4957E89E3F3E7375E11B946CC2326AC39FC2BFFD5359824DDE642711C Participant Details
- createdAtMillis - 1684954443808
- tweetId - 1661170599354400769
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The Newman-Goldfarb protocol is a well-studied, safe practice for inducing lactation of healthy breast milk in both cis women and trans women who have undergone sufficient hormone replacement therapy. Read more: https://www.nytimes.com/2018/02/15/health/transgender-woman-breast-feed.html Peer-reviewed case studies: https://www.liebertpub.com/doi/10.1089/trgh.2017.0044 https://academic.oup.com/jcem/article/106/5/e2047/6123860?login=false https://www.liebertpub.com/doi/10.1089/trgh.2017.0044
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-05-24 18:54:03 UTC (1684954443808) |
1969-12-31 23:59:59 UTC (-1) |
2023-05-31 02:39:52 UTC (1685500792003) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-05-24 14:55:10 -0500 | Rating Details | |
2023-05-24 18:04:24 -0500 | Rating Details | |
2023-05-24 16:45:32 -0500 | Rating Details | |
2023-05-24 14:33:28 -0500 | Rating Details | |
2023-05-24 14:06:25 -0500 | Rating Details | |
2023-05-24 13:58:11 -0500 | Rating Details | |
2023-05-24 14:54:26 -0500 | Rating Details | |
2023-05-24 17:44:24 -0500 | Rating Details | |
2023-05-24 13:58:19 -0500 | Rating Details | |
2023-05-24 14:27:39 -0500 | Rating Details | |
2023-05-24 14:20:56 -0500 | Rating Details | |
2023-05-24 15:39:51 -0500 | Rating Details | |
2023-05-24 17:32:38 -0500 | Rating Details | |
2023-05-24 14:18:51 -0500 | Rating Details | |
2023-05-24 15:12:45 -0500 | Rating Details | |
2023-05-24 14:32:14 -0500 | Rating Details | |
2023-05-24 13:56:55 -0500 | Rating Details | |
2023-05-24 15:11:59 -0500 | Rating Details | |
2023-05-24 18:17:50 -0500 | Rating Details | |
2023-05-24 17:35:48 -0500 | Rating Details | |
2023-05-24 18:46:05 -0500 | Rating Details | |
2023-05-24 14:49:42 -0500 | Rating Details | |
2023-05-24 15:10:38 -0500 | Rating Details | |
2023-05-24 15:35:14 -0500 | Rating Details | |
2023-05-24 16:31:04 -0500 | Rating Details | |
2023-05-24 15:31:42 -0500 | Rating Details | |
2023-05-25 12:37:44 -0500 | Rating Details | |
2023-05-24 21:44:31 -0500 | Rating Details | |
2023-05-25 04:14:53 -0500 | Rating Details | |
2023-05-24 21:26:40 -0500 | Rating Details | |
2023-05-24 21:07:27 -0500 | Rating Details | |
2023-05-25 01:13:00 -0500 | Rating Details | |
2023-05-25 00:38:21 -0500 | Rating Details | |
2023-05-25 11:16:41 -0500 | Rating Details | |
2023-05-25 07:36:29 -0500 | Rating Details | |
2023-05-24 20:00:53 -0500 | Rating Details | |
2023-05-25 13:44:36 -0500 | Rating Details | |
2023-05-25 00:21:12 -0500 | Rating Details | |
2023-05-25 09:15:41 -0500 | Rating Details | |
2023-05-24 23:31:51 -0500 | Rating Details | |
2023-05-25 07:33:42 -0500 | Rating Details | |
2023-05-25 15:16:34 -0500 | Rating Details | |
2023-05-25 12:19:19 -0500 | Rating Details | |
2023-05-25 23:09:16 -0500 | Rating Details | |
2023-05-26 02:27:33 -0500 | Rating Details | |
2023-05-29 09:08:36 -0500 | Rating Details | |
2023-05-26 20:53:11 -0500 | Rating Details | |
2023-06-04 13:57:08 -0500 | Rating Details | |
2023-06-04 23:55:17 -0500 | Rating Details | |
2023-07-07 07:49:59 -0500 | Rating Details |